\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={A Review on Small Ruminants Brucellosis},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2018-01-15 (revised: 15 January 2018)}
\def\TheID{\makeatother }
\def\TheDate{2018-01-15}
\title{A Review on Small Ruminants Brucellosis}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{Tewodros  Alemneh}

             \affil[1]{  University of Gondar}

\renewcommand\Authands{ and }

\date{\small \em Received: 15 December 2017 Accepted: 5 January 2018 Published: 15 January 2018}

\maketitle


\begin{abstract}
        


Brucellosis is an important zoonotic disease that causes huge economic losses to the livestock owners and is of great public health concern worldwide. It is a chronic infectious disease of livestock, rodents, marine animals and human beings. Brucellosis affects both public and animal health as well as production, and is widespread in many regions of the world. The disease is caused by non-motile, facultative intracellular Cocco-bacilli of genus Brucella. The two specific isolates of Brucella, Brucella melitensis and Brucella ovis, cause brucellosis in small ruminants. Brucella ovis causes the disease in sheep while B. melitensis is the etiologic agent of brucellosis in man, sheep and goats. Direct contact with infected animal secretions, inhalation of the organism, ingestion of contaminated food, and poor hygienic practices favor the transmission of brucellosis between animals and humans. Brucellosis affects the reproductive tract of animals which is manifested by late term abortions, retention of placenta in the case of female animals, epididymitis and orchitis in males. The disease is also characterized by infertility and reduced milk production. The diagnosis of brucellosis focuses on culture, serological tests and molecular investigations. Because of the high relapse rate associated with the disease, the use of a multidrug therapy is recommended. Brucellosis can be prevented by implementing appropriate animal-disease-control measures; avoiding the consumption of undercooked meat and unpasteurized dairy products; and using appropriate barrier precautions to exclude exposure to aerosols in humans.

\end{abstract}


\keywords{brucellosis, brucella melitensis, brucella ovis, small ruminants, zoonosis, humans.}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 
\section[{I. Introduction}]{I. Introduction}\par
mall ruminants, which account for more than half of the domesticated ruminants in the world, are an important component of the farming systems in most developing countries \hyperref[b25]{(Gebremedhin et al., 2015)}. Recent studies in different regions of the world indicate that the global population of small ruminants increased from 1.35 billion to 1.94 billion \hyperref[b62]{(Tedeschi et al., 2011)}.\par
Small ruminants are an integral part of livestock keeping in developing countries, especiallyin Sub-Saharan Africa that are mainly keep for immediate cash sources, milk, meat, wool, manure, and saving or risk distribution. Small ruminants also have various social and cultural functions that vary among different cultures, socio-economies, agro-ecologies, and locations in tropical and subtropical Africa \hyperref[b28]{(Gobena, 2016)}. Sheep and goats have many advantages over large ruminants for most smallholder farmers, including among others: fewer feed costs, quicker turnover, easy management and appropriate size at slaughter \hyperref[b75]{(Zahra et al., 2014)}. They also have greater tolerance to less favorable conditions, as they suffer far less in mortality during periods of drought than large ruminants. Also, breeders prefer sheep and goats as the risk of losing large ruminants is too high \hyperref[b75]{(Zahra et al., 2014)}.\par
Ethiopia is one of the African countries with the largest small ruminant population in the continent \hyperref[b0]{(Abebe 2013)}. A recent estimate indicates that there are about 27.35 million sheep and 28.16 million goats in the country  {\ref (CSA, 2014)}. Almost all of the small ruminant populations comprise of local breeds. The CSA data further indicates that of those who own small ruminants, about 64\% and 58\% own less than five heads of sheep and goats, respectively \hyperref[b25]{(Gebremedhin et al., 2015)}.\par
Despite the importance of small ruminants in the livelihoods of producers, the current productivity of goats and sheep in developing countries remains low, mainly due to under-feeding, poor management system and diseases \hyperref[b27]{(Gizaw 2010}). Brucellosis is one of the infectious diseases considered as most constraints for sheep and goats productivity \hyperref[b66]{(Tewodros and Dawit, 2015)}. Brucellosis is an economically important and widespread zoonosis in the world caused by bacteria of the genus Brucella, which tend to infect specific animal species \hyperref[b5]{(Awah-Ndukum et al., 2018)}.\par
Brucellosis occurs worldwide in domestic animals such as cattle, sheep, goats, camels and pigs and creates a high economic problem for both the intensive and extensive livestock production system in the tropics and a threat to public health. It shows that brucellosis causes high economic losses in the livestock industry. Economic losses stem from breeding efficiency, loss of offspring, reduced meat and milk production as well as an impediment to free animal movements and export of animals and their products \hyperref[b66]{(Tewodros and Dawit, 2015)}.\par
Brucellosis is a zoonotic infectious disease affecting a wide range of species of animals and humans with an estimated half a million human cases reported annually \hyperref[b37]{(Kelkay et al., 2017)}. Cattle, goats, pigs, sheep, horses, and dogs play a significant role in the transmission of this disease to man. It is also defined as a contagious systemic bacterial disease primarily of ruminants, characterized by inflammation of the genital organs and fetal membranes, abortion, sterility, and formation of localized lesions in the lymphatic system and joints \hyperref[b5]{(Awah-Ndukum et al., 2018)}. Additionally, the disease also poses a major constraint to international trading of animal and animal products \hyperref[b55]{(Seleem et al., 2010)}. As the problemoften goes undetected, identification of infected herd and animals is of prime importance for the control of the disease. Having large livestock resource at hand coupled with an intermingling of livestock species may cause uninfected animals to easily get exposed to the disease from multiple sources such as abortion discharges and direct contact with infected animals. Mixed farming especially raising goats and sheep along with cattle was also reported by many researchers to be a risk factor for Brucella transmission between different animal species (Padilla et al., 2010, \hyperref[b29]{Godfroid et al., 2013)}.\par
Therefore, this review is undertaken with the objectives of compiling currently available information worldwide about brucellosis in small ruminants and humans, and creating awareness regarding the disease to animal producers, product users, researchers, and investigators. 
\section[{II. Origin and Classification a) Brucella and Brucellosis}]{II. Origin and Classification a) Brucella and Brucellosis}\par
Brucellosis is an infectious disease caused by the genus Brucella. It is a disease of worldwide importance and affects some animal species \hyperref[b63]{(Tegegn et al., 2016)}. Brucellais smallcocci, Cocco-bacilli or short rods, they are 0.5-0.7 by 0.6-1.5 pm in size, nonsporulating and non-encapsulated and nonacid-fast bacteria which stain gram-negative. Brucellosis is an important zoonotic disease of worldwide importance and affects some animal species. The causal organism is first isolated by Bruce in1870 from the liver of a patient died of undulant fever (Malta fever)  {\ref (Hirsh et al., 2004, Khan and}\hyperref[b38]{Zahoor, 2018)}  \hyperref[b55]{(Seleem et al., 2010)}.\par
The different species cannot be distinguished from each other morphologically. For microscopic demonstration in or outside of tissues, selective staining methods are applied which can show the tiny bacteria (Stamper Hansen's staining). For culturing Brucella require complex media. They grow best if special peptones, like tryptose and trypticase-soya-peptone, are added to the medium at a neutral PH and 3-10\% CO2 atmosphere with an incubation temperature of 37°C is required. Delicate translucent colonies of 2-3 mm in diameter grow on blood or glucose-agar. Brucella ovis (B. ovis) always grows in the M-(mucoid) form, Brucella abortus (B. abortus) and B. melitensis grow at the beginning in the S-(smooth) form later dissociate into the R-(rough) and the M-form \hyperref[b50]{(Radostits et al., 2007)}. 
\section[{III. Brucellosis in Small Ruminants}]{III. Brucellosis in Small Ruminants}\par
Brucella melitensis is the most important cause of brucellosis which primarily affects sheep and goats and also very pathogenic for human beings. The disease is also caused by B. ovis which severely affects sheep. Although the disease has preferred hosts, the bacteria can cross-infect other domestic animals. Hence, sporadic infections in small ruminants can also be caused by B. abortus or B. suis, but such cases are rare (OIE, 2012a; \hyperref[b37]{Kelkay et al., 2017)}.\par
The species B. melitensis is the causal organism of brucellosis in small ruminants and undulating or "Malta fever" in humans. Brucella melitensis primarily affect the reproductive tract of sheep and goats, and it is characterized by abortion, retained fetal membrane and to a lesser extent, impaired fertility. Although B. melitensis infects mainly sheep and goats and its zoonotic importance, plays a significant role in the national economy and the public health of many developing countries. Before B. melitensis was recognized as the same symptoms in regions hindering the Mediterranean was known as tibris andulans \hyperref[b50]{(Radostits et al., 2007)}.\par
The disease caused by the infection of sheep with B. ovis is characterized by infertility in rams due to epididymitis. Abortion and neonatal mortality are also caused by the infection \hyperref[b50]{(Radostits et al., 2007)}. 
\section[{IV. Epidemiology a) Occurrence and Geographical Distribution}]{IV. Epidemiology a) Occurrence and Geographical Distribution}\par
Brucellosis is of major economic importance in most countries of the world, and it affects approximately 50\% of the livestock population worldwide and continues to increase in distribution (OIE, 2012a Brucella melitensis and B. ovis create an economic problem for the intensive and extensive animal production systems of the tropics. While the disease has been eradicated in most industrial countries, especially in Europe, through intensive schemes of control and eradication, its occurrence is increasing in developing countries in an even aggravating epizootological situation. This depends on the policy of many developing countries of importing exotic high production breeds without having the required veterinary infrastructure and the appropriate level of development of the socioeconomic situation of the animal holder. Furthermore, the increasing international animal trade with increasing movements of animals and the trend towards intensification of animal production favor the spread and transmission of the infection \hyperref[b50]{(Radostits et al., 2007)}.      
\section[{b) Occurrence in Ethiopia}]{b) Occurrence in Ethiopia}\par
The states of brucellosis of the small ruminant in Ethiopia are not well known or are not more than mere report. This may be due to the lack of attention given to small ruminant production sector. The absence of research activity in animal diseases, poor veterinary development, lack of awareness of the economic and zoonotic impact of the disease have contributed to the less amount of information observed. Though limited, sero-surveillances carried out so far indicate that brucellosis may be one of the important diseases in goat rising communities. A sero-surveillance study carried out 
\section[{Medical Research}]{Medical Research}\par
Volume XVIII Issue II Version I( D D D D ) G A Review on Small Ruminants Brucellosis\par
in small ruminants in different regions clearly demonstrated that the disease exists in Ethiopia. According to the currentsero-surveillance findings of the disease in the country, low infection rate was recorded at Bahir Dar Town of Amhara Regional State \hyperref[b19]{(Ferede et al., 2011}) and the highest was reported at Tellalak District of Afar Regional State \hyperref[b61]{(Tadeg et al., 2015)} (Table \hyperref[tab_6]{5}).The existence of the disease was also confirmed and reported in Southern Nations Nationalities and Peoples Regional state (SNNPRS) of Ethiopia, according to the annual report of Soda Regional Veterinary Laboratory in the year 2005 (Table \hyperref[tab_6]{5}).  
\section[{c) Modes of Transmission}]{c) Modes of Transmission}\par
The primary route of infection is through ingestion of contaminated feed and water, inhalation during overcrowding, contact through intact skin and conjunctiva, lambs may be infected while in the uterus or by suckling infected milk of their mother. Venereal transmissions by the infected ram to susceptible ewes appear to be rare. Transmission may occur by artificial insemination \hyperref[b50]{(Radostits et al., 2007)}. Transmission between animals occurs readily after massive exposure to aborted materials, contaminated placenta and postpartum discharge in an infected female. In sheep, the degree of infection of milk and in uterine exudates is much lesser than goats. Studies indicate that 70-90\% cause of Brucella infection occurs via the skin and mucus membrane by direct contact \hyperref[b22]{(Franc et al., 2018)} (See the mode of transmissions in figure 1).\par
Transmission to man is as a result of contact with infected animal carcasses, aborted fetus, placenta, consumption of unpasteurized milk and cheese. It is common to observe human cases that are in contact with goats in an area where active brucellosis outbreak occurs. Raw vegetable and water contaminated with the extra of infected animals can also serve as a source of infection. Brucella organisms can remain viable in milk, water, and damp soil for up to four months \hyperref[b50]{(Radostits et al., 2007)}.  
\section[{d) Communicability of the Disease between Humans}]{d) Communicability of the Disease between Humans}\par
Brucellosis is not usually transmit from person to person. Rarely, bacteria have been transmitting by bone marrow transplantation, blood transfusion or sexual intercourse \hyperref[b68]{(Wikipedia, 2018)}. Rare congenital infections have also been documented. In some cases, the infant appeared to be infected through the placenta and in others by the ingestion of breast milk. Brucellosis was reported in an obstetrician infected infants respiratory tract at birth \hyperref[b54]{(Saxena et al., 2018)}. 
\section[{V. Zoonotic aspects of Brucellosis}]{V. Zoonotic aspects of Brucellosis}\par
It is considered by the Food and Agriculture Organization (FAO), the World Health Organization (WHO) and the Office International des Epizooties (O1E) as one of the widest spread zoonosis in the world. Reported incidence in endemic disease areas varies widely, from< 0.01 to > 200 per 100,000 populations .\par
The bacterium B. melitensis is the most invasive and pathogenic for humans among the three classical species (B. abortus, B. melitensis and B. suis) of the genus Brucella. Brucellosis remains a most serious zoonosis in areas of the world where B. melitensis is enzootic in goats and sheep, and the resulting disease in human is severe and long lasting \hyperref[b50]{(Radostits et at, 2007)}. Human brucellosis is widely distributed all over the world, with regions of high endemicity such as Mediterranean, Middle East, Latin America and parts of Asia \hyperref[b38]{(Khan et al., 2018)}.\par
Brucellosis due to B. melitensis is a zoonotic disease causing a debilitating illness in human. Symptoms of acute brucellosis caused by B. melitensis are flu-like and highly nonspecific. Chronic brucellosis is an insidious/dangerous disease with vague/unclear symptoms that might be confused with other disease affecting various organ systems \hyperref[b37]{(Kelkay et al., 2017)}.\par
The risk for infection is high in cultures that cohabit with their animals or when weak, infected newborn animals are brought in to the house for warmth and intensive care. Flaw milk and cheese products from infected goats and sheep provide a risk for human and were the mechanism for the occurrence of Malta fever that initiated the definition of the disease \hyperref[b50]{(Radostits et al., 2007)}. 
\section[{VI. Risk Factors}]{VI. Risk Factors}\par
The factors influencing the epidemiology of brucellosis infection in any geographical location can be classified into factors associated with the transmission of the disease between herds and factors influencing the maintenance and spread of infection within the herd (WHO, 2006). Factors associated with brucellosis include host factors (age, sex, and breed), agent and extrinsic factors (environmental factors) including management and ecology \hyperref[b31]{(Guven et al., 2013}\hyperref[b34]{, Hotez et al., 2012)}.\par
It is widely accepted that susceptibility increases with sexual development and pregnancy \hyperref[b31]{(Guven et al., 2013)}. Kids and lambs may become infected before or soon after birth, and tend to become free from infection before reaching breeding age, occasionally infection persist much longer  {\ref (WHO, 2006)}. Brucella melitensis infection causes disease only in adult (sexually mature) females and males. Young animals may be infected but do not show any clinical sign and generally show only a weak and transient serological response \hyperref[b50]{(Radostits et al., 2007)}.\par
In B. melitensis infection males of sheep and goat are less susceptible than females. Brucella ovis has a great affinity for the reproductive tract of the male than the female. Breeding ewes with infected rams seldom cause the disease in ewe and incidence of abortion is low  {\ref (WHO, 2006)}.\par
Animals of an exotic breed and their hybrid are found to be at higher risk. This may associate with better producers and intensively managed  {\ref (Rossetti et al., 2017)}. Most breeds of goats are fully susceptible to B. melitensis. There is great variation in the susceptibility of different breeds of sheep, where Malta sheep are very resistant whereas fat-tailed sheep are very susceptible  {\ref (WHO, 2006)}.\par
Brucella is intracellular bacteria, hence has protection from the innate host defense and from therapeutics, moreover in quiescent state does not cause formation of humeral antibodies \hyperref[b31]{(Guven et al., 2013)}.\par
Humidity and PH of the environment influence the survival of B. melitensis. The organism is sensitive to direct sunlight, disinfectant, and pasteurization  {\ref (WHO, 2006)}.\par
Brucella survives for up to 4 months in milk, urine, water and damp soil under proper environmental condition  {\ref (WHO, 2006)}. Disinfectants like caustic soda, formalin 2\%, and Lysol 1\% destroy Brucella \hyperref[b50]{(Radostits et al., 2007)}.\par
The husbandry systems as well as environmental conditions greatly influence the spread of infection. Thus lambing in the dark, crowded enclosures is more favorable to spread than lambing in the open air in a dry environment. The spread of infection between flocks generally follows the movement or gathering of infected animals. The main risk for introducing the disease into a previously non-infected area is by the purchase of infected animals. In several countries, there is a strong correlation between the prevalence of brucellosis in small ruminants and the practice of transhumance \hyperref[b38]{(Khan et al., 2018)}. 
\section[{VII. Pathogenesis}]{VII. Pathogenesis}\par
The initiation of Brucella infection depends on exposure dose, virulence of Brucella species and the natural resistance of the animal to the organism  {\ref (Radostits et}  infection is on the basis of host's ability to prevent the establishment of infection by the distraction of the invading organism. Invading Brucellais usually localized in the lymph nodes, draining the invasion site, resulting in hyperplasia of lymphoid and reticuloendothelial tissue and the infiltration of inflammatory cells. Survival of the first line of defense by the bacteria results in local infection and the escape of Brucella from the lymph nodes into the blood \hyperref[b61]{(Tadeg et al., 2015)}. During the bacteremic case, which may last 2-8 weeks, bones, joints, eyes, and brain can be infected, but the bacteria are most frequently isolated from super mammary lymph nodes, milk, iliac lymph nodes, spleen and uterus \hyperref[b50]{(Radostits et al., 2007)}.\par
There is preferential localization to the reproductive tract of the pregnant animals. Unknown factors in the gravid uterus collectively referred to as allantoic fluid factors, stimulate the growth of Brucella. Erythritol, a four-carbon alcohol, is considered to be one of these factors. Abortion is associated with the extensive replication of the brucellae within the chorioallantoic trophoblasts that form a vital component of the placenta. This massive intracellular replication ruptures the infected trophoblasts and allows the bacteria direct access to the fetus. The resulting loss of placental integrity and fetal infection lead to termination of the pregnancy or the premature birth of a weak and infected calf \hyperref[b34]{(Hotez et al., 2012)}. Localization in the placenta leads to the development of placentitis with subsequent abortion. After an abortion, the uterine infection persists for up to 5 months, and mammary gland may remain infected first years \hyperref[b50]{(Radostits et al., 2007} {\ref , Saxenaet al., 2018)}.\par
There is initial bacteremia, often with a mild systemic reaction, and the organism can be isolated from the internal organs of animals slaughtered after experimental infection. However, systemic disease is not a feature of the natural disease, and clinical disease results from localization in this area results in sperm stasis and extravasations with a subsequent immunological reaction which is usually in the tail and unilateral, causing a spermatocele and therefore reduced fertility. Not all infected rams have palpable lesions in the epididymis and infection can also establish in the seminal vesicles. In either case, it is shed in the ejaculate. Testicular and epididymal lesions can be palpated at about nine weeks after infection but may occur earlier in some rams. A significant proportion of infected rams have no palpable lesions but still excrete the organism \hyperref[b50]{(Radostits et al., 2007)}. This disease is well described by its original name undulant fever. The disease does not have precise symptoms besides general malaise, making it difficult to diagnose clinically. Brucellosis is characterized by acute fever, sweats, headaches, and flu-like symptoms in the humans . It is believed that brucellosis causes fewer spontaneous abortions than it does in animals because of the absence of erythritol in the human placenta and fetus. An additional reason for the lesser role of Brucella infection in human is the presence of anti-Brucella activity in human amniotic fluid \hyperref[b34]{(Hotez et al., 2012)}. 
\section[{VIII. Clinical Findings}]{VIII. Clinical Findings}\par
The primary clinical manifestations of brucellosis are related to the reproductive tract. The biggest problem of Brucella infection is the uncertain incubation period, which may vary between 15 days to month and years depending on the invasion site, infective dose, and others (FAO, 2010).The only symptom noted under natural infection is abortion. Infected goats show abortion and sometimes mastitis, with reduced milk production. Abortion usually occurs at 3-4 month of pregnancy. Goats that have aborted once are not likely to occur the second time, but sheep may abort a second time. Retention of the fetal membrane may or may not occur (FAO, 2010). Goats shade Brucella in milk for years, but sheep may shade during one or more lactation period. Execration in the vaginal fluid and urine may last for the 4-6 month (FAO, 2010). The first reactions in males are a marked deterioration in the quality of the semen together with the presence of leukocytes and Brucella. Acute edema and inflammation of the scrotum may follow, a systemic reaction, including fever, depression, and increased respiratory rate, accompanies the local reaction. Regression of the acute syndrome is followed latter a long latent period, by the development of palpable lesion in the epididymis and tunica of one or both testicles. The epididymis is enlarged and hard, more commonly at the tail, the scrotal tunics are thickened and hardened, and the testicles are usually atrophic. The groove between the testicle and epididymis may be obliterated. There is usually no clinical sign in the ewe, but in some flocks, infection causes abortion and the birth of week and stillborn lambs and kids, associated with microscopic placentitis \hyperref[b50]{(Radostits et al., 2007)}. 
\section[{IX. Necropsy Findings}]{IX. Necropsy Findings}\par
The abortus is characterized by thickening and edema, sometimes restricted to only a part of the placenta, firm, elevated yellow-white plaques in the intercotyledonary areas. The average degree of abnormality of the cotyledons, which is in the acute stages are much-enlarged, firm and yellow-white in color. When abortion occurs, the organism can be isolated from the placenta and the stomach and lungs of the lamb. Although placentitis is uncommon, it is occasionally seen in infected ewes \hyperref[b50]{(Radostits et al., 2007)}. Some aborted fetuses appear normal others are autolysis or have variable amounts of subcutaneous edema and bloodstained fluid in the body cavities. In ruminant fetuses, the spleen and liver may enlarge, and the lungs may exhibit/show sign of pneumonia and fibrous pleuritis. Abortion caused by Brucella species are typically accompanied by placentitis. The cotyledons may be red, yellow, normal or necrotic. In small ruminants, the intercotyledonary region is typically leathery, with a wet appearance and focal thickening. There may be exudates on the surface. In adults, granulomatous to purulent lesions may found in the male and female reproductive tract, mammary gland, supra mammary lymph node, other lymphoid tissues, bones, joints and other tissues and organs. Mild to severe endometritis may be seen after an abortion, and males can have unilateral or bilateral epididymitis and/or orchitis  {\ref (Saxenaet al., 2018)}. In rams infected with B. ovis, lesions are usually limited to epididymis and orchitis. Epididymal enlargement can be unilateral or bilateral, and the tail is affected more than the head or body. Fibrous atrophy can occur in the testis. The tunica vaginalis is often thickened and fibrous and can have extensive adhesions. In the acute stage, there is inflammatory edema in the loose scrotal fascia, exudates in the tunica vaginalis and early granulation tissue formation. In the chronic stage, the tunics of the testes become thickened and fibrous, and adhesions develop between them  {\ref (Radostits et al., 2000} {\ref ,Saxenaet al., 2018)}.\par
Brucellosis is responsible for massive economic losses around the world especially in developing countries where accurate data are not available to truly assess the loss. Losses are usually due to culling of animals, abortion, infertility, reduced milk production, treatments costs of animals, vaccines, market losses, losses due to missed reproductive cycles, hospitalizations for human cases and administrative costs by governments in an attempt to control or eradicate the infection. In Latin America, annual economic losses were \$600 million for ruminant brucellosis, and in the United States, the eradication program spent \$3.5 billion between 1934 and 1997 and loss due to reduced milk production in 1952 amounting to about \$400 million (Bamaiyiet al., 2014). In assessing the economic impact of brucellosis in case of a bioterrorist attack, it will have an economic impact of \$477.7 million per 100,000 persons exposed. Many other losses due to loss of foetus, decreased milk yield, infertility, interference with farrowing management and sequential seasonal calving, joint infections, weakling calves, disease in man and others could not be accounted for financially but are likely to run into millions of dollars annually (Bamaiyiet al., 2014) (figure 2). Diagnosis and control of the disease in animals must be carried out on a herd basis. There may be a very long incubation period in some infected animals and individuals may remain serologically negative for a considerable period following infection. The identification of one or more infected animals is sufficient evidence that infection is present in the herd, and that other serologically negative animals may be incubating the disease and present a risk \hyperref[b66]{(Tewodros and Dawit, 2015)}. 
\section[{X. Economic Impact of Brucellosis}]{X. Economic Impact of Brucellosis}\par
Diagnostic tests fall into two categories: those that demonstrate the presence of the organisms and those that detect an immune response to its antigens  {\ref (WHO, 2006)}. The isolation of Brucella is definitive proof that the animal is infected, but not all infected animals give a positive culture, and the methods and facilities that must be employed are not always readily available \hyperref[b38]{(Khan et al., 2018)}. The detection of an antibody or a hypersensitivity reaction provides only a provisional diagnosis, but in practice is the most feasible and economical means of diagnosis. False positive reactions to serological tests can occur through some factors, including vaccination, and this must be borne in mind when interpreting results. Similarly, dermal hypersensitivity only indicates previous exposure to the organism, not necessarily an active infection, and may also result from vaccination  {\ref (WHO, 2006)}.\par
Laboratory diagnosis based on direct examination of clinical specimens using modified acidfast stains, bacterial culture and serology (Arifet al., 2018). However, achievement of a reliable diagnosis of brucellosis is a tedious process since isolation is affected by some factors, such as high fastidious nature of Brucella, the presence of a lesser number of viable organisms in the sample and delay in the sample submission (leading to putrefaction). Also, a prolonged incubation period may lead to a failure in its isolation \hyperref[b32]{(Hanci et al., 2017)}.\par
Direct demonstration of the causal organism can be done microscopically with staining examination, fluorescence serologically, cultural on special nutrients, in animal experiments with guinea pigs. Primary bacteriological diagnosis can be made on smears from vaginal swabs, milk, placentas or aborted fetuses stained with stamps method. Confirmation on appropriate culture and selective media is recommended. Spleen and lymph nodes are most reliable from necropsy material. Polymerase chain reaction (PCR) is potentially a useful method on samples containing a low number of Brucella \hyperref[b42]{(Musallam et al., 2016)}. Some of the most used diagnostic tests by indirect demonstration of the pathogen are Card test (C1) is the most suitable for detecting infected flocks and for a survey. It is simple and rapid and does not require laboratory facilities \hyperref[b38]{(Khan et al., 2018)}. Milk ring test (MR7) this procedure is valuable in screening dairy cows and has limitations in the diagnosis of caprine and ovine brucellosis. A serious disadvantage of the test is that its use is limited to milking animals. Allergic skin test (A81) is characteristic of brucellosis in man and some animals and appears through the delayed type of hypersensitivity to Brucella allergens in generalized infection, and the sensitivity may persist for several years \hyperref[b42]{(Musallam et al., 2016)}   {\ref (WHO, 2006)}.\par
Most studies agree that the ELISA is as specific as the CFT, but it is more sensitive. Yet, for a reliable diagnosis of infected animals studies suggest using the ELISA in combination with other tests \hyperref[b40]{(Mohseni et al., 2017)}. Other studies consider the ELISA suitable for screening flocks of sheep and goats for brucellosis \hyperref[b13]{(Currò et al., 2012)}. 
\section[{XII. Treatment}]{XII. Treatment}\par
As a general rule, treatment of infected livestock is not attempted because of the high treatment failure rate, cost, and potential problems related to maintaining infected animals in the face of ongoing eradication programs (Yousefi-Nooraie et al., 2012).\par
Even though the complex nature of brucellosis makes it difficult to treat, long-term treatment with an antibiotic is thought to be beneficial. In most cases, antibiotics in combination are found to be more effective against the infection, however, the state of the disease still does not lose its importance  {\ref (Falagas and Bliziotis, 206, Moon, 2014)}. Several conventional antibiotics including tetracycline, trimethoprim -sulfamethoxazole, amino-glycosides, rifampicin, quinolones, chloramphenicol, doxycycline, and streptomycin are commonly used in clinics \hyperref[b53]{(Saltoglu et al., 2002}\hyperref[b26]{, Geyik et al., 2002)}. In several cases, the application of antibiotics in a speci fic order has given best results. Likewise , a case reported that treatment with doxycycline for six months, followed by streptomycin for three weeks was found very effective against brucellosis in human (Yousefi-Nooraie et al  \hyperref[b6]{(Azimi et al., 2018)}. The World Health Organization recommends that acute brucellosis cases be treated with oral doxycycline and rifampicin (600 mg for six weeks) \hyperref[b17]{(Ersoy et al., 2005)}. However, rifampicin monotherapy is in common practice for treating brucellosis in pregnant women, and combined therapy of sulphamethoxazole and trimethoprim is recommended for children  {\ref (Karabayet al., 2004)}. In underdeveloped countries, treatment of cattle is not a common practice, however, the infected animals are isolated, culled or slaughtered to prevent the spreading of infection to other herd and at substantial veterinary costs. In China, a case of subdural empyema complicated by intracerebral abscess due to Brucella infection was effectively treated with antibiotic therapy (ceftriaxone, doxycycline, rifapentine) \hyperref[b76]{(Zhang et al., 2017)}. In line with this, several reports suggested the combination therapy of doxycycline and rifampicin for six weeks is enough to eradicate Brucella infection, as well as associated complications \hyperref[b39]{(Meng et al., 2018}\hyperref[b36]{, Kaya et al., 2018)}. This combination of doxycycline and rifampicin has also been proven experimentally \hyperref[b71]{(Yang et al., 2018)}. As a result of continued efforts by the scientific community to develop an effective therapeutics, Caryopterismongolica Bunge (Lamiaceae) has been tested in combination with doxycycline \hyperref[b67]{(Tsevelmaa et al., 2018}\hyperref[b54]{, Saxena et al., 2018)}. Even though several therapeutics are in practice which makes the disease manageable, an effective therapeutic is required for the complete treatment of brucellosis \hyperref[b38]{(Khan et al., 2018)}.\par
Humans are treated with antibiotics (doxicycline with rifamipicine). Relapses are, however, possible (Solis and Solera, 2012). In experimentally infected rams the combined administration of chlortetracycline (800mg intravenously) and streptomycin (lgram subcutaneously) injected daily for 21 days, eliminated infection. Streptomycin alone and streptomycin plus sulfadimidine were not satisfactory. Treatment is economically practicable only in valuable rams and must be instituted before irreparable damage to the epididymis has occurred. A dose of 1000 mg of long-acting tetracycline give every three days for the period of 6 weeks achieved a cure rate of 75\% \hyperref[b50]{(Radostits et al., 2007)}. 
\section[{XIII. Control and Prevention}]{XIII. Control and Prevention}\par
As the ultimate source of human brucellosis is direct or indirect exposure to infected animals or their products, prevention must be based on elimination of such contact. The obvious way to do this-elimination of the disease from animals is often beyond the financial and human resources of many developing countries. The technical and social difficulties involved in eradicating B. melitensis from small ruminants have even taxed the resources of some developed countries. In many situations, there is little alternative but to attempt to minimize the impact of the disease and to reduce the risk of infection by personal hygiene, adoption of safe working practices, protection of the environment and food hygiene. The lack of safe, effective, widely available vaccines approved for human use means that prophylaxis currently plays little part in the prevention of human disease  {\ref (WHO, 2006)}.\par
Prevention and control of brucellosis can be adopted realistically through an understanding of local and regional variations in animal husbandry practices, social customs, infrastructures and epidemiological patterns of the disease \hyperref[b15]{(Dorneles et al., 2015)}. The common approaches used to control brucellosis includes quarantine of imported stoke and decide for or against immunization of the negative animals \hyperref[b50]{(Radostits et al., 2007)}.\par
Eradication by test and slaughter principles are based on the magnitude of disease prevalence and economic status at countries and handling hygienic disposal of aborted fetuses, fetal membrane and discharges with subsequent disinfection of contaminated area  {\ref (WHO, 2006)}.\par
Control measures must include hygiene at lambing and the disposal of infected or reactor animals. Separate pens for lambing ewes, which can be cleaned and disinfected, early weaning of lambs from their dams, and their environment and vaccination, are recommended. In endemic areas, all placentas and dead fetuses should be buried as a routine practice. The need to test and cull, introduced and resident animals likely to be carriers is recommended, but difficult to be effective because of the inaccuracy of the tests. Because of the possibility that lambs may be infected at birth and carry the disease for life, it may be more economical to dispose off the entire flock \hyperref[b50]{(Radostits et al., 2007)}.\par
The experience from all over the world, that vaccination is in most situations the only practical method of control of brucellosis in sheep and goats. Immunization with effective vaccines helps to get the infection under control, limit its spread, prevent human infections and reduce economic losses \hyperref[b42]{(Musallam et al., 2016)}. Most workers agree that the smooth live organisms of B. abortus strain 19 and B. melitensis Rev 1have many advantages over inactivated vaccines. Their limitations, including interference with diagnostic tests, are well known. However, they provide good protection on a herd per flock basis by reducing clinical symptoms (exposure potential) and elevating to induce sexually mature animals. The reduced doses also reduce the physiologic and serologic effects. It is illogical to restrict the use of vaccines among mature animals where there are no controls on infected populations \hyperref[b14]{(Donev, 2010)}. Brucellosis is thought to be widespread zoonotic infectious disease that highly affects the health and economy of animals and humans in the world. The two species of Brucella, B. ovis and B. melitensis, are the main causative agents of infection to sheep and goats, respectively. The latter, is also the one in which, greatly contributes the infection to humans. 
\section[{Medical Research}]{Medical Research}\par
The disease is serious, therefore, proper veterinary legislation must be implemented and policies regarding animal health need to be encouraged. Current and modern awareness on brucellosis should be delivered to farmers, veterinary professionals, and health educators, especially for rural populations, which will help to prevail over the dispersal of Brucella infection worldwide. Effective and relatively safe vaccines should be available to provide long-term protection against brucellosis in both animals and humans.\par
In general, to combat the disease, there should be proper management practices such as rearing of brucellosis free animals, isolating and restricting movement of infected and/or suspected animals, following the guidelines of incineration or burial for proper disposal of animal discharges and wastes, formulating a schedule for cleansing and disinfection of animal houses, feeding and watering troughs, and understanding proper hygienic practices in all stages.  
\section[{Medical Research}]{Medical Research}\begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-2.png}
\caption{\label{fig_0}}\end{figure}
    \begin{figure}[htbp]
\noindent\textbf{} \par 
\begin{longtable}{}
\end{longtable} \par
  {\small\itshape [Note: (Benkirane, 2006). B. abortus is mainly found in cattle and buffaloes, B. suis in pigs, B. ovis in sheep and B. canis in dogs]} 
\caption{\label{tab_0}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{1} \par 
\begin{longtable}{P{0.24555555555555553\textwidth}P{0.2752380952380952\textwidth}P{0.10253968253968254\textwidth}P{0.22666666666666666\textwidth}}
Continent / Country / Region\tabcellsep Distribution Brucella Melitensis\tabcellsep Brucella Ovis\tabcellsep Reference\\
\tabcellsep Asia\tabcellsep \tabcellsep \\
Armenia\tabcellsep Present\tabcellsep Not Reported\tabcellsep Oie, 2009\\
Azerbaijan\tabcellsep ,,\tabcellsep ,,\tabcellsep Oie, 2009\\
China\tabcellsep Restricted Distribution\tabcellsep ,,\tabcellsep Oie, 2009\\
Georgia (Republic Of)\tabcellsep Last Reported In 1991\tabcellsep ,,\tabcellsep Oie Handistatus, 2005\\
Iran\tabcellsep Present\tabcellsep ,,\tabcellsep Oie, 2009\\
Iraq\tabcellsep ,,\tabcellsep ,,\tabcellsep Oie, 2009\\
Israel\tabcellsep ,,\tabcellsep ,,\tabcellsep Oie, 2009\\
Jordan\tabcellsep ,,\tabcellsep ,\tabcellsep \end{longtable} \par
 
\caption{\label{tab_2}Table 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{2} \par 
\begin{longtable}{P{0.17444029850746268\textwidth}P{0.2727611940298507\textwidth}P{0.12845149253731342\textwidth}P{0.1046641791044776\textwidth}P{0.16968283582089552\textwidth}}
\tabcellsep ,\tabcellsep \multicolumn{2}{l}{Not Reported}\tabcellsep Oie Handistatus, 2005\\
Yemen\tabcellsep ,,\tabcellsep \tabcellsep ,,\tabcellsep ,,\\
Continent / Country / Region\tabcellsep \multicolumn{2}{l}{Distribution Brucella Melitensis}\tabcellsep Brucella Ovis\tabcellsep Reference\\
\tabcellsep \multicolumn{3}{l}{North and Central America}\\
Canada\tabcellsep Not Reported\tabcellsep \tabcellsep Absent\tabcellsep Oie, 2009\\
Mexico\tabcellsep Present\tabcellsep \tabcellsep Not Reported\tabcellsep Oie, 2009\\
Usa\tabcellsep Not Reported\tabcellsep \multicolumn{2}{l}{Restricted Distribution}\tabcellsep ,,\\
United States Virgin Islands\tabcellsep Present\tabcellsep \tabcellsep Not Reported\tabcellsep Ahlet Al., 1993\\
\tabcellsep South America\tabcellsep \tabcellsep \\
Argentina\tabcellsep Present\tabcellsep \multicolumn{2}{l}{Restricted Distribution}\tabcellsep Oie, 2009\\
Chile\tabcellsep Not Reported\tabcellsep \multicolumn{2}{l}{Restricted Distribution}\tabcellsep ,,\\
Sao Paulo\tabcellsep Present\tabcellsep \tabcellsep Not Reported\tabcellsep Gouvêaet Al., 1989\\
Peru\tabcellsep Restricted Distribution\tabcellsep \tabcellsep ,,\tabcellsep Oie, 2009\\
Uruguay\tabcellsep Not Reported\tabcellsep \tabcellsep Present\tabcellsep ,,\end{longtable} \par
  {\small\itshape [Note: GA Review on Small Ruminants Brucellosis]} 
\caption{\label{tab_3}Table 2 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{3} \par 
\begin{longtable}{P{0.23378176382660684\textwidth}P{0.2185351270553064\textwidth}P{0.170254110612855\textwidth}P{0.22742899850523166\textwidth}}
Continent / Country / Region\tabcellsep \multicolumn{2}{l}{Distribution Brucella Melitensis Brucella Ovis}\tabcellsep Reference\\
\tabcellsep Europe\tabcellsep \tabcellsep \\
Albania\tabcellsep Present\tabcellsep \tabcellsep Oie, 2009\\
Andorra\tabcellsep ,,\tabcellsep Not Reported\tabcellsep Oie Handistatus, 2005\\
Bulgaria\tabcellsep ,,\tabcellsep Present\tabcellsep Oie, 2009\\
Croatia\tabcellsep ,,\tabcellsep ,,\tabcellsep ,,\\
Cyprus\tabcellsep ,,\tabcellsep Not Reported\tabcellsep ,,\\
Gibraltar\tabcellsep ,,\tabcellsep ,,\tabcellsep Yantzis, 1984\\
Greece\tabcellsep ,,\tabcellsep ,,\tabcellsep Oie, 2009\\
Hungary\tabcellsep Not Reported\tabcellsep Present\tabcellsep ,,\\
Italy\tabcellsep Restricted Distribution\tabcellsep Not Reported\tabcellsep ,,\\
Macedonia\tabcellsep ,,\tabcellsep ,,\tabcellsep Oie, 2009\\
Malta\tabcellsep ,,\tabcellsep ,,\tabcellsep Abela, 1999, Oie, 2009\\
Moldova\tabcellsep ,,\tabcellsep ,,\tabcellsep Oie Handistatus, 2005\\
Portugal\tabcellsep ,,\tabcellsep ,,\tabcellsep Oie, 2009\\
Romania\tabcellsep Not Reported\tabcellsep Present\tabcellsep ,,\\
Russian\tabcellsep ,,\tabcellsep ,,\tabcellsep ,,\\
Serbia\tabcellsep ,,\tabcellsep Not Reported\tabcellsep ,,\\
Slovenia\tabcellsep Not Reported\tabcellsep Present\tabcellsep ,,\\
Spain\tabcellsep Present\tabcellsep Restricted Distribution\tabcellsep ,,\\
Yugoslavia\tabcellsep ,,\tabcellsep Not Reported\tabcellsep Oie Handistatus, 2005\\
\tabcellsep Oceania\tabcellsep \tabcellsep \\
Australia\tabcellsep Not Reported\tabcellsep Present\tabcellsep Oie, 2009\\
New Caledonia\tabcellsep ,,\tabcellsep \tabcellsep \end{longtable} \par
 
\caption{\label{tab_4}Table 3 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{4} \par 
\begin{longtable}{P{0.5390939597315436\textwidth}P{0.20251677852348993\textwidth}P{0.10838926174496645\textwidth}}
Country\tabcellsep Brucella Melitensis\tabcellsep Brucella Ovis\\
Egypt\tabcellsep +\tabcellsep ND\\
Ethiopia\tabcellsep +\tabcellsep ND\\
Kenya\tabcellsep +\tabcellsep ND\\
Sudan\tabcellsep +\tabcellsep ND\\
Somalia\tabcellsep +\tabcellsep ND\\
Eritrea\tabcellsep +\tabcellsep +\\
Libya\tabcellsep +\tabcellsep ND\\
Lesotho\tabcellsep ND\tabcellsep +\\
Algeria\tabcellsep +\tabcellsep +\\
Tunisia\tabcellsep ++\tabcellsep ND\\
Namibia\tabcellsep +\tabcellsep +\\
Niger\tabcellsep +\tabcellsep +\\
Nigeria\tabcellsep +\tabcellsep ND\\
Cotd' Ivor\tabcellsep ND\tabcellsep +\\
Zimbabwe\tabcellsep +\tabcellsep +\\
Botswana\tabcellsep ND\tabcellsep +\\
South Africa\tabcellsep +\tabcellsep +\\
\tabcellsep \multicolumn{2}{l}{Source: (FAO, 2010; OIE, 2012b)}\\
\multicolumn{3}{l}{(++: High prevalence, +: Sporadic low prevalence, ND: No Data)}\end{longtable} \par
 
\caption{\label{tab_5}Table 4 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{5} \par 
\begin{longtable}{P{0.022641509433962263\textwidth}P{0.369811320754717\textwidth}P{0.10283018867924527\textwidth}P{0.0830188679245283\textwidth}P{0.27169811320754716\textwidth}}
Sr. No.\tabcellsep Study Area\tabcellsep Region\tabcellsep Prevalence\tabcellsep Source\\
1\tabcellsep Tellalak District\tabcellsep Afar\tabcellsep 13.7\%\tabcellsep Tadeg et al., 2015\\
2\tabcellsep Chifra and Ewa Districts\tabcellsep Afar\tabcellsep 12.35\%\tabcellsep Tegegn et al., 2016\\
3\tabcellsep Yabello districts of Borena Zone,\tabcellsep Oromia\tabcellsep 8.1\%\tabcellsep Wubishet et al., 2018\\
4\tabcellsep Liban District of Guji Zone\tabcellsep Oromia\tabcellsep 6.2\%\tabcellsep Wubishet et al., 2017\\
5\tabcellsep Southern Zone of Tigray\tabcellsep Tigray\tabcellsep 3.5\%\tabcellsep Teklue et al., 2013\\
6\tabcellsep Selected Export Abattoirs\tabcellsep Addis Ababa\tabcellsep 2.7\%\tabcellsep Nigatu et al., 2014\\
7\tabcellsep Werer Agricultural Research Center\tabcellsep Afar\tabcellsep 2.25\%\tabcellsep Bezabih and Bulto, 2015\\
8\tabcellsep Selected Pastoral and Agro-pastoral Lowlands of Ethiopia\tabcellsep Somali and Oromia\tabcellsep 1.9\%\tabcellsep Sintayehu et al., 2015\\
9\tabcellsep Southern and Central Ethiopia\tabcellsep SNNP and Oromia\tabcellsep 1.9 \%\tabcellsep Asmare et al., 2012\\
10\tabcellsep Tselemti Districts\tabcellsep Tigray\tabcellsep 1.79\%\tabcellsep Kelkay et al., 2017\\
\tabcellsep South Wollo\tabcellsep Amhara\tabcellsep 1.5\%\tabcellsep Yesuf et al., 2011\\
11\tabcellsep Three Selected districts of Jijiga Zone\tabcellsep Somali\tabcellsep 1.37\%\tabcellsep Mohammed et al., 2017\\
12\tabcellsep In and Around Kombolcha\tabcellsep Amhara\tabcellsep 0.7\%\tabcellsep Tewodros and Dawit, 2015\\
13\tabcellsep In and Around Bahir Dar\tabcellsep Amhara\tabcellsep 0.4 \%\tabcellsep Ferede et al., 2011\end{longtable} \par
 
\caption{\label{tab_6}Table 5 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{} \par 
\begin{longtable}{P{0.6303370786516854\textwidth}P{0.09550561797752809\textwidth}P{0.047752808988764044\textwidth}P{0.028651685393258425\textwidth}P{0.047752808988764044\textwidth}}
\tabcellsep .\tabcellsep \tabcellsep \tabcellsep \\
Individual\tabcellsep Serologic\tabcellsep Tests\tabcellsep are\tabcellsep Serum\\
\multicolumn{5}{l}{Agglutination Tube Test (SAT), Complement Fixation}\\
Test (\tabcellsep \tabcellsep \tabcellsep \tabcellsep \end{longtable} \par
 
\caption{\label{tab_7}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{} \par 
\begin{longtable}{P{0.85\textwidth}}
A Review on Small Ruminants Brucellosis\\
jatrorrhizine was more effective against brucellosis\\
caused by B. abortus compared to a combination of\\
streptomycin and rifampicin\\
Volume XVIII Issue II Version I\\
D D D D ) G\\
(\\
Medical Research\\
Global Journal of\end{longtable} \par
 
\caption{\label{tab_8}}\end{figure}
 			\footnote{© 2018 Global Journals} 			\footnote{© 2018 Global JournalsGlobal Journal of} 			\footnote{© 2018 Global Journals 1} 		 		\backmatter   			 
\subsection[{Acknowledgements}]{Acknowledgements}\par
The Authors greatly acknowledge those who participated either directly or indirectly in supplying materials and logistics that highly contributed for the success of this work. 			  			 
\subsection[{Conflicting of Interest:}]{Conflicting of Interest:}\par
Authors declare that no conflict of interest in the publication of this work.			 			  				\begin{bibitemlist}{1}
\bibitem[ Statistical Bull. PP]{b12}\label{b12} 	 		\textit{},  	 	 		\textit{Statistical Bull. PP}  		p. 573.  	 
\bibitem[Microbiol]{b56}\label{b56} 	 		\textit{},  		 			Microbiol 		.  		140 p. .  	 
\bibitem[Plosnegl and Trop ()]{b52}\label{b52} 	 		\textit{},  		 			Plosnegl 		,  		 			Trop 		.  		. Dis. 2017, 11, e0005692.  	 	 (Pub Med) 
\bibitem[Hirsh and Maclachlan ()]{b33}\label{b33} 	 		\textit{},  		 			D C Hirsh 		,  		 			N J Maclachlan 		,  		 			WalkerR 		.  	 	 		\textit{Veterinary Microbiology. Black well science USA}  		2004. p. .  	 
\bibitem[Teklue et al. ()]{b64}\label{b64} 	 		\textit{},  		 			T Teklue 		,  		 			T Tolosa 		,  		 			G Tuli 		,  		 			B Beyene 		,  		 			B Hailu 		.  		2013.  	 
\bibitem[Godfroid et al. ()]{b29}\label{b29} 	 		‘A "One Health" surveillance and control of brucellosis in developing countries: Moving away from improvisation’.  		 			J Godfroid 		,  		 			Al Dahouk 		,  		 			S Pappas 		,  		 			G Roth 		,  		 			F Matope 		,  		 			G Muma 		,  		 			J Marcotty 		,  		 			T Pfeiffer 		,  		 			D Skjerve 		,  		 			E 		.  	 	 		\textit{Comp. Immunol. Microbial. Infect. Dis}  		2013. 36  (3)  p. .  	 
\bibitem[Yang et al. ()]{b71}\label{b71} 	 		‘A case report of spontaneous abortion caused by Brucella melitensis biovar 3’.  		 			H X Yang 		,  		 			J J Feng 		,  		 			X Q Zhang 		,  		 			E R Hao 		,  		 			X S Yao 		,  		 			R Zhao 		,  		 			R D Piao 		,  		 			Y B Cui 		,  		 			H Jiang 		.  	 	 		\textit{Infect. Dis. Poverty}  		2018. 7 p. 31.  	 	 (Pub Med) 
\bibitem[Mohseni et al. ()]{b40}\label{b40} 	 		‘A comparative evaluation of ELISA, PCR, and serum agglutination tests for diagnosis of Brucella using human serum’.  		 			K Mohseni 		,  		 			R Mirnejad 		,  		 			V Piranfar 		,  		 			S Mirkalantari 		.  	 	 		\textit{Iran J. Pathol}  		2017. 12 p. .  	 	 (Pub Med) 
\bibitem[Saxena and Raj ()]{b54}\label{b54} 	 		‘A novel immunotherapy of Brucellosis in cows monitored non-invasively through a speci fic biomarker’.  		 			H M Saxena 		,  		 			S Raj 		.  	 	 		\textit{PLoSNegl. Trop. Dis}  		2018. 12 p. e0006393.  	 	 (Pub Med) 
\bibitem[Zahra et al. ()]{b75}\label{b75} 	 		\textit{A review of Ethiopia small ruminant value chains from a gender perspective. Nairobi: ILRI and ICARDA},  		 			A Zahra 		,  		 			A Mulema 		,  		 			K Colverson 		,  		 			D Odongo 		,  		 			B Rischkowsky 		.  		2014. p. .  	 
\bibitem[Asmare et al. ()]{b4}\label{b4} 	 		\textit{A study on seroprevalence of caprine brucellosis under three livestock production systems in southern and central Ethiopia. Trop Anim Health Prod},  		 			K Asmare 		,  		 			B Megersa 		,  		 			Y Denbarga 		,  		 			G Abebe 		,  		 			A Taye 		,  		 			J Bekele 		,  		 			T Bekele 		,  		 			E Gelaye 		,  		 			E Zewdu 		,  		 			A Agonafir 		,  		 			G Ayelet 		,  		 			E Skjerve 		.  		 \xref{http://dx.doi.org/10.1007/s11250-012-0258-2}{10.1007/s11250-012-0258-2}.  		2012. 45 p. .  	 
\bibitem[Foster et al. ()]{b21}\label{b21} 	 		‘African lineage Brucella melitensis isolates from Omani livestock’.  		 			J T Foster 		,  		 			M F Walker 		,  		 			D B Rannals 		,  		 			H M Hussain 		,  		 			P K Drees 		,  		 			V R Tiller 		,  		 			R A Hoffmaster 		,  		 			A Al-Rawahi 		,  		 			P Keim 		.  	 	 		\textit{Front. Microbiol}  		2017. 2702. 8.  	 	 (Pub Med) 
\bibitem[Khan and Zahoor ()]{b38}\label{b38} 	 		‘An Overview of Brucellosis in Cattle and Humans, and its Serological and Molecular Diagnosis in Control Strategies’.  		 			M Z Khan 		,  		 			M Zahoor 		.  	 	 		\textit{Trop. Med. Infect. Dis}  		2018. 3 p. 65.  	 
\bibitem[Tsevelmaa et al. ()]{b67}\label{b67} 	 		‘Anti-Brucella activity of Caryopterismongolica Bunge root extract against Brucella melitensis infection in mice’.  		 			N Tsevelmaa 		,  		 			B Narangerel 		,  		 			O Odgerel 		,  		 			D Dariimaa 		,  		 			J Batkhuu 		.  	 	 		\textit{BMC Complement. Altern. Med}  		2018. 18 p. 144.  	 
\bibitem[Yousefi-Nooraie et al. ()]{b74}\label{b74} 	 		‘Antibiotics for treating human brucellosis’.  		 			R Yousefi-Nooraie 		,  		 			S Mortaz-Hejri 		,  		 			M Mehrani 		,  		 			P Sadeghipour 		.  	 	 		\textit{Cochrane Database Syst. Rev}  		2012. Cd007179. 10.  	 	 (Pub Med) 
\bibitem[Abebe et al. ()]{b0}\label{b0} 	 		‘Assessment of sheep marketing system in Burie district’.  		 			Y Abebe 		,  		 			S Melaku 		,  		 			A Tegegne 		.  	 	 		\textit{North Western Ethiopia. Wudpecker Journal of Agricultural Research}  		2013. 2  (3)  p. .  	 
\bibitem[Azimi et al. ()]{b6}\label{b6} 	 		‘Bioassay -directed isolation of quaternary benzylisoquinolines from Berberisintegerrima with bactericidal activity against Brucella abortus’.  		 			G Azimi 		,  		 			A Hakakian 		,  		 			M Ghanadian 		,  		 			A Joumaa 		,  		 			S Alamian 		.  	 	 		\textit{Res. Pharm. Sci}  		2018. 13 p. .  	 
\bibitem[Bovine brucellosis OIE Manual of diagnostic tests and vaccines for terrestrial animals ()]{b45}\label{b45} 	 		‘Bovine brucellosis’.  	 	 		\textit{OIE Manual of diagnostic tests and vaccines for terrestrial animals},  				 (Paris)  		2012a. p. .  	 	 (Office International des Epizooties Terrestrial Manual (OIE)) 
\bibitem[Brucella melitensis in Eurasia and the Middle East. FAO Animal Production and Health Proceedings ()]{b20}\label{b20} 	 		\textit{Brucella melitensis in Eurasia and the Middle East. FAO Animal Production and Health Proceedings},  		2010. Rome: Food and Agriculture Organization of the United Nations.  	 
\bibitem[Yantzis ()]{b72}\label{b72} 	 		‘Brucella melitensis in Greece: current situation report. Brucella melitensis.CEC seminar’.  		 			D Yantzis 		.  	 	 		\textit{Veterinary Medicine and Animal Science}  		1985. November 1984. 32 p. .  	 	 (Current Topics in) 
\bibitem[Cabi ()]{b10}\label{b10} 	 		\textit{Brucellosis (Brucella melitensis)},  		 			Cabi 		.  		 \url{https://www.cabi.org/isc/datasheet/90734}  		2017b. 2018.  	 	 (Retrieved 06 14) 
\bibitem[Cabi ()]{b9}\label{b9} 	 		\textit{Brucellosis (Brucella ovis)},  		 			Cabi 		.  		 \url{https://www.cabi.org/isc/datasheet/90731}  		2017a. 2018.  	 	 (Retrieved 06 14) 
\bibitem[Donev ()]{b14}\label{b14} 	 		‘Brucellosis control and eradication in the south eastern European countries: Current status and perspective strategies. Maced’.  		 			D Donev 		.  	 	 		\textit{J. Med. Sci}  		2010. 3  (220) .  	 
\bibitem[Neharika Saxena, Balbir Bagicha Singh and Hari Mohan Saxena. ()]{b43}\label{b43} 	 		‘Brucellosis in Sheep and Goats and Its Serodiagnosis and Epidemiology’.  		 \xref{http://dx.doi.org/10.20546/ijcmas.2018.701.225}{10.20546/ijcmas.2018.701.225}.  		 \url{https://doi.org/10.20546/ijcmas.2018.701.225}  	 	 		\textit{Int. J. Curr. Microbiol. App. Sci}  		Neharika Saxena, Balbir Bagicha Singh and Hari Mohan Saxena. (ed.)  		2018. 7  (01)  p. .  	 
\bibitem[Franc et al. ()]{b22}\label{b22} 	 		‘Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action’.  		 			K A Franc 		,  		 			R C Krecek 		,  		 			B N Häsler 		,  		 			A Arenas-Gamboa 		.  	 	 		\textit{BMC Public Health}  		2018. 18 p. 125.  	 
\bibitem[Seleem et al. ()]{b55}\label{b55} 	 		\textit{Brucellosis: A re-emerging zoonosis},  		 			M N Seleem 		,  		 			S M Boyle 		,  		 			N Sriranganathan 		.  		2010.  	 	 (Vet) 
\bibitem[Rossetti et al.]{b51}\label{b51} 	 		\textit{Caprine brucellosis: A historically neglected disease with signi ficant impact on public health},  		 			C A Rossetti 		,  		 			A M Arenas-Gamboa 		,  		 			E Maurizio 		.  		 	 
\bibitem[Ersoy et al. ()]{b17}\label{b17} 	 		‘Comparison of three different combination therapies in the treatment of human brucellosis’.  		 			Y Ersoy 		,  		 			E Sonmez 		,  		 			R M Tevfik 		,  		 			D A But 		.  	 	 		\textit{Trop. Doct}  		2005. 35 p. .  	 	 (Pub Med) 
\bibitem[Kaya et al. ()]{b36}\label{b36} 	 		‘Cytopenia in adult brucellosis patients’.  		 			S Kaya 		,  		 			N Elaldi 		,  		 			O Deveci 		,  		 			E A Eskazan 		,  		 			M Bekcibasi 		,  		 			S Hosoglu 		.  	 	 		\textit{Indian J. Med. Res}  		2018. 147 p. .  	 	 (PubMed) 
\bibitem[Padilla Poiester et al. ()]{b49}\label{b49} 	 		‘Diagnosis of Brucellosis’.  		 			F Padilla Poiester 		,  		 			K Nielsen 		,  		 			Ernesto Samartino 		,  		 			L 		,  		 			Ling Yu 		,  		 			W 		.  	 	 		\textit{Open Vet. Sci. J}  		2010. 4 p. 46.  	 
\bibitem[Saltoglu et al. ()]{b53}\label{b53} 	 		‘Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis’.  		 			N Saltoglu 		,  		 			Y Tasova 		,  		 			S A Inal 		,  		 			T Seki 		,  		 			S H Aksu 		.  	 	 		\textit{Saudi Med. J}  		2002. 23 p. .  	 	 (Pub Med) 
\bibitem[Sintayehu et al. ()]{b58}\label{b58} 	 		‘Epidemiological survey of brucellosis in sheep and goats in selected pastoral and agro-pastoral lowlands of Ethiopia’.  		 			G Sintayehu 		,  		 			B Melesse 		,  		 			Abayneh A D Sintayehu 		,  		 			A Melaku 		,  		 			S 		.  	 	 		\textit{Rev. Sci. Tech. Off. Int. Epiz}  		2015. 2015.  (3)  p. 34.  	 
\bibitem[Abela ()]{b1}\label{b1} 	 		\textit{Epidemiology and control of brucellosis in ruminants from 1986 to 1996 in Malta},  		 			B Abela 		.  		1999. 18 p. .  	 	 (Revue Scientifiqueet Technique -Office International des épizooties) 
\bibitem[Hanci et al. ()]{b32}\label{b32} 	 		‘Evaluation of a new and rapid serologic test for detecting brucellosis: Brucella Coombs gel test’.  		 			H Hanci 		,  		 			H Igan 		,  		 			M H Uyanik 		.  	 	 		\textit{Pak. J. Biol. Sci}  		2017. 20 p. .  	 	 (Pub Med) 
\bibitem[Arif et al. ()]{b3}\label{b3} 	 		‘Evaluation of three serological tests for diagnosis of bovine brucellosis in smallholder farms in Pakistan by estimating sensitivity and specificity using Bayesian latent class analysis’.  		 			S Arif 		,  		 			J Heller 		,  		 			M Hernandez-Jover 		,  		 			M D Mcgill 		,  		 			C P Thomson 		.  	 	 		\textit{Prev. Vet. Med}  		2018. 149 p. .  	 	 (PubMed) 
\bibitem[Gebremedhin et al. ()]{b25}\label{b25} 	 		\textit{Factors determining household market participation in small ruminant production in the highlands of Ethiopia},  		 			B Gebremedhin 		,  		 			D Hoekstra 		,  		 			A Tegegne 		,  		 			K Shiferaw 		,  		 			A Bogale 		.  		2015. Nairobi, Kenya.  		 			International Livestock Research Institute 		 	 	 (LIVES Working Paper 2) 
\bibitem[Federal Democratic Republic of Ethiopia, Central Statistical Agency, Agricultural sample survey on livestock and livestock characteristics (Private Peasant Holdings) ()]{b11}\label{b11} 	 		‘Federal Democratic Republic of Ethiopia, Central Statistical Agency, Agricultural sample survey’.  	 	 		\textit{on livestock and livestock characteristics (Private Peasant Holdings)},  				2014. 2013. 2006. II.  		 			Central Statistical Agency (CSA 		 	 	 (Report) 
\bibitem[Gizaw ()]{b27}\label{b27} 	 		 			S Gizaw 		.  		\textit{Sheep and goat production and marketing systems in Ethiopia: Characteristics and strategies for improvement},  				2010.  	 	 (ILRI (aka ILCA and ILRAD)) 
\bibitem[Franco et al. ()]{b23}\label{b23} 	 		‘Human brucellosis’.  		 			M P Franco 		,  		 			M Mulder 		,  		 			H R Gilman 		,  		 			L Smits 		.  	 	 		\textit{Lancet Infect. Dis}  		2007. 7 p. .  	 
\bibitem[Franco et al. ()]{b24}\label{b24} 	 		‘Human brucellosis’.  		 			M P Franco 		,  		 			M Mulder 		,  		 			H R Gilman 		,  		 			L H Smits 		.  	 	 		\textit{Lancet Infect. Dis}  		2007. 7 p. .  	 
\bibitem[Sohn et al. ()]{b59}\label{b59} 	 		‘Human neurobrucellosis with intra cerebral granuloma caused by a marine mammal Brucella spp’.  		 			A H Sohn 		,  		 			W S Probert 		,  		 			C A Glaser 		.  	 	 		\textit{Emerging Infectious Diseases Journal}  		2003. 9 p. .  	 
\bibitem[Geyik et al. ()]{b26}\label{b26} 	 		‘Musculoskeletal involvement of brucellosis in different age groups: A study of 195 cases’.  		 			M F Geyik 		,  		 			A Gur 		,  		 			K Nas 		,  		 			R Cevik 		,  		 			J Sarac 		,  		 			B Dikici 		,  		 			C Ayaz 		.  	 	 		\textit{Swiss Med. Wkly}  		2002. 132 p. .  	 	 (Pub Med) 
\bibitem[Hotez et al. ()]{b34}\label{b34} 	 		‘Neglected tropical diseases of the Middle East and North Africa: Review of their prevalence, distribution, and opportunities for control’.  		 			P J Hotez 		,  		 			L Savioli 		,  		 			A Fenwick 		.  	 	 		\textit{PLoSNegl. Trop. Dis}  		2012, 6, e1475.  	 	 (Pub Med) 
\bibitem[Guven et al. ()]{b31}\label{b31} 	 		‘Neurobrucellosis: Clinical and diagnostic features’.  		 			T Guven 		,  		 			K Ugurlu 		,  		 			O Ergonul 		,  		 			K A Celikbas 		,  		 			E S Gok 		,  		 			S Comoglu 		,  		 			N Baykam 		,  		 			B Dokuzoguz 		.  	 	 		\textit{Clin. Infect. Dis}  		2013. 56 p. .  	 	 (Pub Med) 
\bibitem[Gouvêa et al. ()]{b30}\label{b30} 	 		\textit{Occurrence of brucellosis in goats from Sao Paulo State. Arquivos do Instituto Biológico},  		 			G Gouvêa 		,  		 			E Roxo 		,  		 			Mabs Lima 		,  		 			D Homerich 		.  		1989. Sao Paulo. p. 60.  	 	 (Supl) 
\bibitem[Karabay et al. ()]{b35}\label{b35} 	 		‘Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: A randomized clinical trial [ISRCTN11871179’.  		 			O Karabay 		,  		 			I Sencan 		,  		 			D Kayas 		,  		 			I Sahin 		.  	 	 		\textit{BMC Infect. Dis}  		2004. 4.  	 	 (Pub Med) 
\bibitem[El Abdin et al.]{b16}\label{b16} 	 		‘Prevalence and Risk Factors of Ruminants Brucellosis in Jabel Aolia Locality’.  		 			S Z El Abdin 		,  		 			T E Angara 		,  		 			A A Elfadil 		,  		 			E M El Sanousi 		,  		 			A Ibrahim 		.  	 	 		\textit{Sudan. Sudan Journal of Science and Technology}  		15  (2)  p. .  	 
\bibitem[Falagas and Bliziotis ()]{b18}\label{b18} 	 		‘Quinolones for treatment of human brucellosis: Critical review of the evidence from microbiological and clinical studies’.  		 			M E Falagas 		,  		 			I A Bliziotis 		.  	 	 		\textit{Antimicrob. Agents Chemother}  		2006. 50 p. .  	 	 (Pub Med) 
\bibitem[Dorneles et al. ()]{b15}\label{b15} 	 		‘Recent advances in Brucella abortus vaccines’.  		 			E M Dorneles 		,  		 			N Sriranganathan 		,  		 			A P Lage 		.  	 	 		\textit{Vet. Res}  		2015. 46.  	 	 (Pub Med) 
\bibitem[Gobena ()]{b28}\label{b28} 	 		‘Review on Small Ruminant Production, Marketing and Constraints in Ethiopia’.  		 			M Gobena 		.  	 	 		\textit{Advances in Life Science and Technology},  				 (V (48)  		2016. p. .  	 
\bibitem[Meng et al. ()]{b39}\label{b39} 	 		‘Rifampicin versus streptomycin for brucellosis treatment in humans: A meta-analysis of randomized controlled trials’.  		 			F Meng 		,  		 			X Pan 		,  		 			W Tong 		.  	 	 		\textit{PLoS One}  		2018. e0191993. 13.  	 	 (Pub Med) 
\bibitem[Sharifi et al. ()]{b57}\label{b57} 	 		‘Risk facts of small ruminant brucellosis: a crosssectional study in Southeast Iran’.  		 			H Sharifi 		,  		 			K Mashayekhi 		,  		 			M M Tavakoli 		.  	 	 		\textit{Human \& Veterinary Medicine. International Journal of the Bioflux Society}  		2015. 2012. 7 p. .  	 
\bibitem[Kelkay et al. ()]{b37}\label{b37} 	 		‘Sero-prevalence and associated risk factors for Brucella sero-positivity among small ruminants in Tselemti districts’.  		 			M Z Kelkay 		,  		 			G Gugsa 		,  		 			Y Hagos 		,  		 			H Taddelle 		.  	 	 		\textit{Northern Ethiopia. Journal of Veterinary Medicine and Animal Health}  		2017. 9  (11)  p. .  	 
\bibitem[Sero-prevalence and risk factors study of brucellosis in small ruminants in Southern Zone of Tigray Region Northern Ethiopia. Trop. Anim. Health Prod]{b65}\label{b65} 	 		‘Sero-prevalence and risk factors study of brucellosis in small ruminants in Southern Zone of Tigray Region’.  	 	 		\textit{Northern Ethiopia. Trop. Anim. Health Prod}  		45 p. .  	 
\bibitem[Wubishet et al.]{b69}\label{b69} 	 		\textit{Sero-Prevalence Of Brucellosis In Goats And Community Awareness In Liban District Of Guji Zone, Oromia Regional State, Southern Ethiopia},  		 			Z Wubishet 		,  		 			D Golo 		,  		 			F Chala 		,  		 			A Shubisa 		,  		 			H Huqa L Godana 		,  		 			D Ararsa 		.  		 DOI: 10.19080/ JOJPH.2017.02.555587.  		JOJ Pub Health. 2017 p. 555587.  	 
\bibitem[Nigatu et al. ()]{b44}\label{b44} 	 		‘Sero-Prevalence of Brucellosis in Sheep and Goat Destined for Slaughter in Selected Export Abattoirs’.  		 			S Nigatu 		,  		 			M Deneke 		,  		 			T Kassa 		.  	 	 		\textit{Ethiopia. African Journal of Basic \& Applied Sciences}  		2014. 6  (3)  p. .  	 
\bibitem[Tewodros ()]{b66}\label{b66} 	 		‘Sero-Prevalence of Small Ruminant Brucellosis in and around Kombolcha, Amhara Regional State, North-Eastern Ethiopia’.  		 			A E Tewodros 		,  		 			DawitA 		.  	 	 		\textit{J. Vet. Sci. Med. Diagn}  		2015. 4  (5) .  	 
\bibitem[Ahl (1993)]{b2}\label{b2} 	 		‘Serological evidence for the presence of Brucella antibodies in sheep and goats on Saint Croix’.  		 			A S Ahl 		,  		 			BartlettP C 		,  		 			FrerichsW 		.  	 	 		\textit{Actes de la 2e Réunion Biennale de la Society for Tropical Veterinary Medicine},  				 (s de la 2e Réunion Biennale de la Society for Tropical Veterinary MedicineU.S. Virgin Islands; Saint FranÇois, Guadeloupe)  		1993. 2-6 février 1993. 46 p. .  	 	 (Revue d'élevage et de Médecine Vétérinaire des Pays Tropicaux) 
\bibitem[Mouiche et al. ()]{b5}\label{b5} 	 		‘Seroprevalence and Associated Risk Factors of Brucellosis among Indigenous Cattle in the Adamawa and North Regions of Cameroon’.  		 			Awah-Ndukum J Mouiche 		,  		 			M M M Bayang 		,  		 			H N Ngungwa 		,  		 			N Assana 		,  		 			E Feussom 		,  		 			KJ M 		,  		 			ManchangT K 		,  		 			ZoliP 		.  	 	 		\textit{Vet Med Int}  		2018. 3468596.  	 
\bibitem[Yesuf et al. ()]{b73}\label{b73} 	 		‘Seroprevalence of Ovine Brucellosis in South Wollo’.  		 			M Yesuf 		,  		 			S Alemu 		,  		 			W Temesgen 		,  		 			H Mazengiac 		,  		 			H Negussie 		.  	 	 		\textit{North Eastern Ethiopia. American-Eurasian J. Agric. \& Environ. Sci}  		2010. 9  (3)  p. .  	 
\bibitem[Tadeg and Birru ()]{b61}\label{b61} 	 		‘Seroprevalence of small ruminant brucellosis and its effect on reproduction at Tallalak district of Afar region’.  		 			W M Tadeg 		,  		 			GudetaF R 		,  		 			MekonenT Y 		,  		 			Asfaw Y T Birru 		,  		 			AL 		,  		 			RedaA 		.  	 	 		\textit{Ethiopia. J. Vet. Med. Anim. Health}  		2015. 7  (4)  p. .  	 
\bibitem[Bezabih and Bulto ()]{b8}\label{b8} 	 		‘Seroprevalence of small ruminant brucellosis in Werer Agricultural Research Center’.  		 			M K Bezabih 		,  		 			W C Bulto 		.  	 	 		\textit{Acad. J. Microbiol. Res}  		2015. 3  (2)  p. .  	 
\bibitem[Wubishet et al. ()]{b70}\label{b70} 	 		‘Small Ruminant Brucellosis and Awareness of Pastoralists Community about Zoonotic Importance of the Disease in Yabello districts of Borena Zone Oromia Regional State, Southern Ethiopia’.  		 			Z Wubishet 		,  		 			K Sadik 		,  		 			B Abdala 		,  		 			B Mokonin 		,  		 			T Getachew 		,  		 			K Getachew 		.  		 \xref{http://dx.doi.org/10.19080/CTBEB.2018.12.555827}{10.19080/CTBEB.2018.12.555827}.  	 	 		\textit{Curr Trends Biomedical Eng \& Biosci}  		2018. 12  (1)  p. 555827.  	 
\bibitem[Tegegn et al. ()]{b63}\label{b63} 	 		‘Small Ruminant Brucellosis and Public Health Awareness in Two Districts of Afar Region’.  		 			A H Tegegn 		,  		 			A Feleke 		,  		 			W Adugna 		,  		 			S K Melaku 		.  	 	 		\textit{Ethiopia. J. Vet. Sci. Technol}  		2016. 7  (335)  p. 2.  	 
\bibitem[Ferede et al. ()]{b19}\label{b19} 	 		‘Study on the seroprevalence of small ruminant brucellosis in and around Bahir Dar, North West Ethiopia. Ethiop’.  		 			Y Ferede 		,  		 			D Mengesha 		,  		 			G Mekonen 		,  		 			M Hilemelekot 		.  	 	 		\textit{Vet. J}  		2011. 15  (2)  p. .  	 
\bibitem[Solis Garcia Delpozo and Solera ()]{b60}\label{b60} 	 		‘Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis’.  		 			J Solis Garcia Delpozo 		,  		 			J Solera 		.  	 	 		\textit{PLoS ONE}  		2012. 7.  	 	 (e32090. [Cross Ref. Pub Med) 
\bibitem[Musallam et al. ()]{b42}\label{b42} 	 		‘Systematic review of brucellosis in the Middle East: Disease frequency in ruminants and humans and risk factors for human infection’.  		 			I I Musallam 		,  		 			N M Abo-Shehada 		,  		 			M Y Hegazy 		,  		 			R H Holt 		,  		 			J F Guitian 		.  	 	 		\textit{Epidemiol. Infect}  		2016. 144 p. .  	 	 (Pub Med) 
\bibitem[Currò et al. ()]{b13}\label{b13} 	 		‘The isolation of Brucella spp. from sheep and goat farms in Sicily’.  		 			V Currò 		,  		 			S Marineo 		,  		 			D Vicari 		,  		 			L Galuppo 		,  		 			P Galluzzo 		,  		 			D Nifosì 		,  		 			M Pugliese 		,  		 			A Migliazzo 		,  		 			A Torina 		,  		 			S Caracappa 		.  	 	 		\textit{Small Rumin. Res}  		2012. 106 p. .  	 
\bibitem[Zhang et al. ()]{b76}\label{b76} 	 		‘Treatment of a subdural empyema complicated by intracerebral abscess due to Brucella infection’.  		 			J Zhang 		,  		 			Z Chen 		,  		 			L Xie 		,  		 			C Zhao 		,  		 			H Zhao 		,  		 			C Fu 		,  		 			G Chen 		,  		 			Z Hao 		,  		 			L Wang 		,  		 			W Li 		.  	 	 		\textit{Braz. J. Med. Biol. Res}  		2017. 50 p. e5712.  	 	 (Pub Med) 
\bibitem[Moon ()]{b41}\label{b41} 	 		‘Tuberculosis of spine: Current views in diagnosis and management’.  		 			M S Moon 		.  	 	 		\textit{Asian Spine J}  		2014. 8 p. .  	 	 (Pub Med) 
\bibitem[Bamaiyi et al. ()]{b7}\label{b7} 	 		‘Updates on Brucellosis in Malaysia and South Asia’.  		 			P H Bamaiyi 		,  		 			L Hassan 		,  		 			S Khairani-Bejo 		,  		 			A M Zainal 		.  	 	 		\textit{Malaysian Journal of Veterinary Research}  		2014.  (5)  p. .  	 
\bibitem[Tedeschi et al. ()]{b62}\label{b62} 	 		‘Using system dynamics modelling approach to develop management tools for animal production with emphasis on small ruminants’.  		 			L O Tedeschi 		,  		 			C F Nicholson 		,  		 			E Rich 		.  	 	 		\textit{Small Ruminant Research}  		2011. 98 p. .  	 
\bibitem[Radostits et al. ()]{b50}\label{b50} 	 		\textit{Veterinary Medicine: a text book of the Disease of cattle, sheep, pigs, goats and horse},  		 			O M Radostits 		,  		 			C Gay 		,  		 			D C Blood 		,  		 			K Hinchclift 		.  		2007. London. p. .  	 	 (Harcourt publishers limited) 
\bibitem[Wikipedia ()]{b68}\label{b68} 	 		 			Wikipedia 		.  		 \url{https://en.m.wikipedia.org/wiki/Brucella.66}  	 	 		\textit{Brucellosis in humans and animals. WHO Library Cataloguing-in-Publication Data},  				2018. 2018. 2006. 06 p. .  	 
\bibitem[Oie ()]{b46}\label{b46} 	 		\textit{World Animal Health Information Database -Version: 1.4. World Animal Health Information Database},  		 			Oie 		.  		 \url{http://www.oie.int}  		2009a. Paris, France.  	 
\bibitem[Oie ()]{b47}\label{b47} 	 		‘World Animal Health Information Database.Version 2. World Animal Health Information Database’.  		 			Oie 		.  		 \url{http}  	 	 		\textit{World Organisation for Animal Health}  		2012b.  	 
\bibitem[Oie Handistatus ()]{b48}\label{b48} 	 		\textit{World Animal Health Publication and Handistatus II (data set for},  		 			Oie Handistatus 		.  		2005. 2004.  	 
\end{bibitemlist}
 			 		 	 
\end{document}